/R E P E A T/ - Media advisory - GlaxoSmithKline to make significant announcement regarding its Laval vaccines facility



    MONTREAL, June 7 /CNW Telbec/ - You are invited to attend a press
conference at which significant announcements will be made regarding the
GlaxoSmithKline (GSK) vaccines facility in Laval
    The press conference will take place in the presence of Mr. Raymond
Bachand, Minister of Economic Development, Innovation and Export Trade and
Minister of Tourism, the Honourable Michael M. Fortier, Minister of Public
Works and Government Services Canada, and Minister Responsible for the
Montreal Region, and Mr. Gilles Vaillancourt, Mayor of Laval.
    GSK is one of the world's leading research-based pharmaceutical and
health care companies and is a world leader in the development and
manufacturing of vaccines. GSK is now the largest bio-pharmaceutical employer
in Quebec and across the country.
    
    What:  Press conference followed by photography opportunity

    Who:   - Mr. Raymond Bachand
           - The Honourable Michael M Fortier
           - Mr. Gilles Vaillancourt
           - Mr. Paul Lucas, President and CEO, GlaxoSmithKline, Canada
           - Dr. Nathalie Garçon, Vice-President, Head of Research and North
             America R&D, GlaxoSmithKline Biologicals

    When:  Monday, June 11, 2007 - 10:00 a.m.

    Where: GlaxoSmithKline
           525 Boulevard Cartier West
           Laval, Quebec
    




For further information:

For further information: Roch Landriault, NATIONAL PharmaCom, (514)
843-2345


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890